FDA Accepts Camurus CAM2029 NDA Resubmission; Oczyesa Approved in Australia
During the quarter, the FDA accepted Camurus’ resubmitted NDA for CAM2029 for review in acromegaly, and Oczyesa was approved in Australia.
Related stories
Health Canada Approves Camurus’ Oczyesa XR for Acromegaly
M impact | REGULATION | Nov 05, 2026, 06:06 AM UTC
US Treasury Sanctions India-Based Network Over Iranian Oil Shipments
The Treasury Department sanctioned India-based individuals and businesses, along with a Turkey-based aviation services firm, over alleged support for Iranian oil shipments and airl
M impact | REGULATION | Nov 05, 2026, 05:43 AM UTC
Oman Court of Appeal Nullifies Bankruptcy Judgment Against Sohar Flour Mills
Oman’s Court of Appeal nullified the bankruptcy judgment against Sohar Flour Mills on Nov. 4, 2026.
M impact | REGULATION | Nov 05, 2026, 05:36 AM UTC
India to Mandate Energy Storage for State Power Utilities
India will require state power utilities to use energy storage, the power secretary says.
M impact | REGULATION | Nov 05, 2026, 05:32 AM UTC
India to Mandate Energy Storage for Power Buyers, Secretary Says
India will soon issue regulations requiring all licensed power buyers, including state utilities, to have energy storage, Power Secretary Pankaj Agarwal said.
M impact | REGULATION | Nov 05, 2026, 05:31 AM UTC
Mexico Blocks 40 People and Companies Linked to Election Suppliers
Mexico’s Finance Ministry blocked 40 people and companies linked to election suppliers.
L impact | REGULATION | Nov 05, 2026, 04:33 AM UTC